作者
Rajesh Kethireddy, Darshan Gandhi, Asim Kichloo, Love Patel
发表日期
2022/7/7
来源
World Journal of Critical Care Medicine
卷号
11
期号
4
页码范围
219
出版商
Baishideng Publishing Group Inc
简介
Hyperglycemia is commonly associated with adverse outcomes especially in patients requiring intensive care unit stay. Data from the corona virus disease 2019 (COVID-19) pandemic indicates that individuals with diabetes appear to be at similar risk for COVID-19 infection to those without diabetes but are more likely to experience increased morbidity and mortality. The proposed hypothesis for hyperglycemia in COVID-19 include insulin resistance, critical illness hyperglycemia (stress-induced hyperglycemia) secondary to high levels of hormones like cortisol and catecholamines that counteract insulin action, acute cytokine storm and pancreatic cell dysfunction. Diabetic patients are more likely to have severe hyperglycemic complications including diabetic ketoacidosis and hyperosmolar hyperglycemic state. Management of hyperglycemia in COVID-19 is often complicated by use of steroids, prolonged total …
学术搜索中的文章
R Kethireddy, D Gandhi, A Kichloo, L Patel - World Journal of Critical Care Medicine, 2022